Skip to main content
All Posts By

admin

New Alliance Executive Director takes charge

By News Archive

With more than 15 years as a nonprofit professional, Amanda joins the Fort Detrick Alliance with extensive experience in communications, marketing, fundraising, event planning, public relations, and management. She replaces Eileen Mitchell, who served as Executive Director since December 2015 In her career, Amanda served as the Assistant Director at the Historical Society of Frederick County; Marketing Manager at the National Shrine of Saint Elizabeth Ann Seton; Marketing director of Black Rock Center for the Arts; and Public Relations Specialist at the University System of Maryland at Hagerstown. Amanda has been instrumental in tourism marketing in the region and served for four years on the Tourism Council of Frederick County’s marketing and group sales committees. As a writer and journalist, Amanda published articles in Frederick Magazine, Find It Frederick magazine, Eastern Home and Travel, the Baltimore Sun, and other regional publications. Amanda may be reached at 301-788-9896 or email director@fortdetrickalliance.org Thank you for your continued support of Fort Detrick and the Alliance. We hope to see you at one of our events. If you are interested in becoming a member of the Alliance, please feel free to contact me at director@fortdetrickalliance.org.

Sincerely,

Amanda Johnston Executive Director 

3idx-logo

Local Startup Developing Technology for Real-Time Detection of Bacteria

By News Archive

BHI Q&A with 3i Diagnostics, Inc. President & CEO, Jim Janicki & Chief Technology Officer, Rajesh Krishnamurthy

3idx-logo

Company: 3i Diagnostics, Inc. “3iDx” www.3iDx.com

Location: Germantown Innovation Center/Launch Labs

Founded: 2013

Overview: 3iDx is an early stage company developing a new technology platform that is able to isolate and analyze microbes directly from samples for the purpose of identifying antimicrobial resistant strains in less than an hour without having to wait for up to a week for blood culture results. Their ultimate aim is to create a 15-minute test that runs in a battery powered handheld device.

Read More
astrazeneca-merck-logo

AstraZeneca, Merck & Co. in $8.5-Billion Oncology Collaboration – BioPharm International

By News Archive

astrazeneca-merck-logo

AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s Lynparza (olaparib) for multiple cancer types. Lynparza is an oral poly ADP ribose polymerase (PARP) inhibitor for treating BRCA-mutated ovarian cancer in multiple lines of treatment. It was approved by FDA in December 2014 and generated 2016 sales of $218 million.

Read More
inova-health-system-logo

Inova accelerator seeks personalized-medicine startups Industries | Virginia Business

By News Archive

inova-health-system-logo

The Inova Personalized Health Accelerator (IPHA) is preparing to accept applications from early-stage startups focused on predicting, preventing and treating disease. Falls Church-based Inova Health System announced plans for the accelerator last December when it also launched Inova Strategic Investments, a venture-capital program. Both projects are housed at the new Inova Center for Personalized Health, a 117-acre campus in Fairfax County.

Read More
zcube-logo

Encouraging Life Science Innovation: The Value of Accelerator Programs – Technology Networks

By News Archive

zcube-logo

The road to launching a life science start-up can be a long and difficult one, with founders often struggling to secure funding and manage the logistics of setting up a business. In a move to encourage innovation and help start-ups hit the ground running, there are an increasing choice of accelerator and support programs becoming available.

We spoke to Giovanni Rizzo, PhD MBA Chief of Innovation Division, Z-Cube S.r.l. to learn more about such programs and the difference they can make to innovation, as well as share some tips for academics beginning a start-up venture. 

Read More
sucampo-logo

Sucampo: A Shift Toward Rare Diseases – Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) – Seeking Alpha

By News Archive

sucampo-logo

Sucampo’s (NASDAQ:SCMP) share price has been stuck in a range for a considerable time, but the company wasn’t idle – management has been working hard to move the company away from its legacy product Amitiza into rare diseases. Sucampo made two transactions since early 2016 and now has two late-stage orphan assets (one wholly owned and an option on the other) with data readouts in 2018. Sucampo is generating strong free cash flow and expects to continue to build out its late-stage orphan drug pipeline. Meanwhile, Amitiza has been growing at a steady pace and that’s despite the growing competition in the constipation space. I believe that cash flow from Amitiza provides downside protection while the orphan pipeline stands to add significant value in the long run.

Read More
innovation-bridge-logo

Innovation Bridge Breakfast Series @ The Rockville Innovation Center

By News Archive

innovation-bridge-logo

Tuesday, August 22, 2017 from 8:30 AM to 10:30 AM

The MITRE Corporation, BHI, and Montgomery County Economic Development Corporation are pleased to announce the Innovation Bridge Breakfast Series at the Rockville Innovation Center. We hope you will join us for the first in a quarterly series of technology talks, geared to foster innovation and create connections among the regional entrepreneurial community.Sign-up soon! Registration is limited.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.